Now let me write the final consolidated review.

## Summary

This paper introduces HG-DCM, a framework that combines a deep residual CNN with a compartmental epidemiological model (DELPHI) for early-stage pandemic forecasting. The key idea is to train the neural network jointly on historical pandemic data (Ebola, SARS, Dengue, influenza) and limited current-pandemic data to predict interpretable compartmental model parameters, rather than predicting case counts directly. This aims to address overfitting in the "cold-start" phase when current data is extremely sparse (2–8 weeks).

## Strengths

1. **Well-motivated and clearly articulated problem.** The paper correctly identifies that early-stage pandemic forecasting is fundamentally constrained by data scarcity (Section 1, paragraph 2–3). The analogy to an epidemiologist's "mental library" of historical outbreak curves (Section 1, paragraph 4) effectively motivates why historical data could help.

2. **Architecture preserves epidemiological interpretability.** By having the neural network predict compartmental model parameters (rather than case counts directly) and feeding these into a DELPHI ODE solver (Section 2.1, Eqns. 1–2), the model's intermediate representations remain epidemiologically meaningful. This enables the parameter inference analysis (Section 3.2.3, Figure 5), a capability that pure black-box models lack.

3. **Thoughtful engineering decisions.** The removal of Batch Normalization layers (Section 2.1, paragraph 3) because batch statistics differ across historically distinct pandemics is a non-obvious and well-motivated choice. The window-shift augmentation for past pandemic data (Section 2.2) and the masking augmentation for current pandemic data also reflect genuine engagement with the problem.

4. **Ablation study design is structurally sound.** Comparing HG-DCM against DELPHI (compartmental-only), CNN (deep-learning-only), and T-DCM (HG-DCM without historical data/metadata) is the right conceptual structure for isolating the contribution of each component.

## Weaknesses

### Major

**1. Headline claim overstates the evaluation evidence.** The abstract states HG-DCM "consistently and significantly outperforms state-of-the-art methods" "across 258 global locations." However, the cross-method benchmark against SOTA methods (GradABM, EiNNs, Table 1) is conducted on exactly two locations—the United States and Massachusetts—because "they were the only locations in which there was available data and code for the comparison methods" (Section 3.2.1). The ablation study (Table 2) likely uses more locations, but the paper never states how many, and this table does not include the SOTA competitors. The evidence does not match the scope of the claim. The abstract should be revised to accurately reflect the evaluation scope.

**2. Selective and occasionally inaccurate reporting of ablation results.** The paper's narrative about Table 2 is misleading in several places when checked against the actual numbers:

- The paper claims CNN "generally underperforms HG-DCM across all training horizons" (Section 3.2.2). CNN beats HG-DCM on median MAE at 6 weeks (1,187.8 vs. 1,275.6) and on mean MAE at 4 weeks (11,238.1 vs. 110,452.4—HG-DCM is worse by an order of magnitude).
- The paper describes HG-DCM and DELPHI as having "comparable accuracy" at 6–8 weeks. At 8-week median MAE, DELPHI (537.7) is 48% better than HG-DCM (796.0).
- The gap between mean and median MAE for HG-DCM at 4 weeks (110,452 vs. 1,771—a 62× difference) indicates catastrophic outliers on some locations. The paper relies almost exclusively on median metrics after the introductory narrative, which obscures this instability. These outliers are neither analyzed nor discussed.

**3. No statistical testing of forecasting accuracy differences.** The only statistical test (Wilcoxon signed-rank) is applied to parameter values (Section 3.2.3), not to forecasting accuracy. For Table 1, with only 2 test locations, no meaningful significance test is possible. For Table 2, only point estimates (mean/median) are reported without confidence intervals, standard deviations, or any measure of uncertainty.

### Minor

**4. The T-DCM ablation conflates historical data and metadata.** T-DCM removes both historical pandemic time-series data *and* metadata simultaneously (Section 3.2.2). This makes it impossible to determine whether the improvement relative to HG-DCM comes from historical case data, from country-level metadata (World Bank indicators), or from both—different mechanisms with different implications for the paper's core claim of "history-guided" learning.

**5. Potential data leakage from overlapping historical periods.** Seasonal influenza data spans 2009–2023 (Section 3.1.1). COVID-19 began in 2020. Influenza data from 2020–2023 was collected during the COVID-19 pandemic, when mitigation measures (masking, lockdowns) dramatically altered influenza transmission patterns. If the model learns from this period, it may partly learn COVID-era behavioral confounds rather than universal disease dynamics. This should be discussed.

**6. Missing evaluation details.** The paper does not specify: (a) the number of locations used in the ablation study (Table 2), (b) the β hyperparameter value that weights past vs. current pandemic loss (Eqn. 5), and (c) any measure of variance for forecasting results.

### Trivial

None.

## Nice-to-Haves

- Analyze the catastrophic outliers driving the large mean–median gap at 4 weeks. Identifying where HG-DCM fails and whether those failures share common characteristics would strengthen the paper.
- Disentangle the T-DCM ablation (e.g., HG-DCM minus historical data only vs. HG-DCM minus metadata only) to attribute improvements to the correct mechanism.
- Test whether removing influenza data from 2020–2023 changes the results, to address the data leakage concern.
- Expand the cross-method benchmark beyond 2 locations, or calibrate the abstract's claims to match the evidence.

## Removed Points

- *"The paper claims to be the first study to develop such a framework"* — Kept as a legitimate claim; the paper qualifies it appropriately relative to prior work (Section 1, paragraph 7).
- *"Not releasing the dataset"* — Removed per rules: the dataset is original work, not a cited reference whose existence is being doubted.
- *"Missing related works"* — Removed per rules: cannot verify existence of missing external works.
- *"Reproducibility concerns about undisclosed hyperparameters"* (beyond β) — Removed as generic nitpick.
- *"The central thesis about human social behavior being universal is strained for Dengue"* — Removed as speculative; the paper explicitly says it learns from dynamics, not specific parameter values.
- *Formatting/style nitpicks* — Removed per rules.
- *"The model may systematically underpredict"* based on overshoot analysis — Removed as speculative; the overshoot analysis is properly presented as one of multiple evaluation dimensions.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. Revise the abstract and introduction to accurately reflect that the SOTA comparison was conducted on 2 locations, not 258. The claim should be that HG-DCM was evaluated across 258 locations in ablation studies and benchmarked against SOTA methods on available locations.
2. Report the number of locations used in the ablation study.
3. Honestly discuss the full results in Table 2, including settings where HG-DCM underperforms baselines.
4. Analyze and explain the catastrophic outliers (the mean >> median gap).
5. Report confidence intervals, standard deviations, or IQRs for forecasting results.
6. Disentangle the T-DCM ablation or discuss the confound explicitly.
7. Report the β value used in the loss function.

## Score and Decision

**Calibration Anchors (all papers retrieved across rounds):**

| Path | Avg Score | Round | Comparison |
|---|---|---|---|
| PEMs: Pre-trained Epidemic Time-Series Models (DL7JWbdGr3) | 4.75 | R1 | Most topically similar; same core idea of pre-training across diseases for epidemic forecasting. Both rejected. PEMs has broader evaluation but similar concerns about baselines and disentangling contributions. HG-DCM has more serious overclaiming (258 vs 2 locations) but better architectural novelty and interpretability. |
| Mechanism-Empowered Tuberculosis Prediction (V83xzYnZ5q) | 3.00 | R1 | Much weaker; narrow domain application, no methodological novelty. Not directly comparable. |
| PARAMETER OPTIMIZATION FOR EPIDEMIOLOGICAL MODEL (CpiOUOaqh3) | 2.00 | R1 | Much weaker; simple GA parameter tuning, no deep learning. Not comparable. |
| Mechanistic Neural Networks (Giwj9cgAIl) | 4.67 | R2 | Similar architecture concept (NN predicts ODE parameters) but broader scope. High reviewer score variance (8,3,3). |
| TRENDy (NvDRvtrGLo) | 5.00 | R2 | Learning dynamics from data. Less directly comparable. |
| Generalizing Dynamics Modeling (i1BTP8wFYM) | 5.25 | R2 | Pre-trained dynamics encoder. Less directly comparable. |
| DAM: Towards a Foundation Model for Forecasting (4NhMhElWqP) | 7.00 | R1 | Much stronger evaluation across many datasets; clearly an accept-level paper. |
| Various CloudOps/general time series papers (ZkEsEFFUyo, tdttNKCtyB) | 4.33–5.75 | R2 | Less topically relevant. |

**Round 1 Bracket:** 3.5–5.5 (based on PEMs at 4.75 as the strongest anchor).

**Final Score Determination:** The most informative anchor is PEMs (4.75, Reject). The HG-DCM paper shares the same fundamental idea and similar weaknesses (limited baselines, insufficient disentangling of contributions). However, HG-DCM has a *more serious* overclaiming problem (abstract claims validation "across 258 global locations" when the SOTA comparison is on 2 locations) and selectively reports ablation results (ignoring cases where baselines outperform HG-DCM). On the positive side, HG-DCM's architectural design (neural-guided compartmental model) offers interpretability that PEMs lacks, and the problem framing is strong. The net assessment places HG-DCM slightly below PEMs, at 4.0.

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>